{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:58:15Z","timestamp":1790855895603,"version":"4.1.0"},"reference-count":32,"publisher":"The Journal of Health Economics and Outcomes Research","issue":"1","funder":[{"DOI":"10.13039\/501100002907","name":"Coloplast","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002907","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHEOR"],"abstract":"<jats:p>Background: Neurogenic bowel dysfunction (NBD) is a common sequela in Spinal Cord Injury (SCI) patients. Bowel dysfunction symptoms have a significant negative impact on quality of life (QOL) and are often socially disabling. Transanal irrigation (TAI) is a bowel management procedure that significantly mitigates NBD symptoms in patients refractory to standard bowel care (SBC) by reducing the incidence of fecal incontinence, ameliorating constipation, and improving QOL. TAI devices are used across many countries such as the United Kingdom, Germany, and France, and introduction of the devices is being considered in Japan. In this context, a cost-effectiveness analysis specific to Japanese settings is relevant.\n\nObjectives: To analyze the cost-effectiveness of TAI for bowel management of SCI patients with NBD in a Japanese clinical setting.\n\nMethods: A modified version of a previously developed and published Markov model was used to evaluate the cost-effectiveness of TAI. In the model, SCI patients using TAI due to NBD were compared with SCI patients not responding to TAI and continuing with SBC. Quality-adjusted Life Years (QALYs) were used as the primary effectiveness measure, and the analysis was conducted from the payer\u2019s perspective.\n\nResults: The model predicts a lifetime incremental cost of TAI to be 3 198 687 yen compared with SBC. TAI provided an additional 0.8 QALY, which leads to an incremental cost-effectiveness ratio (ICER) of TAI vs SBC of 4 016 287 yen\/QALY.\n\nConclusions: An ICER of 4 million yen falls within the range of reported willingness to pay (WTP) per QALY gain (5\u20136.7 million yen) in Japan, and TAI is therefore found to be a cost-effective treatment strategy compared to SBC. The result should be further corroborated in future Japanese trials of TAI.<\/jats:p>","DOI":"10.36469\/9781","type":"journal-article","created":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T18:12:32Z","timestamp":1569348752000},"page":"37-52","source":"Crossref","is-referenced-by-count":8,"title":["Cost-Effectiveness Analysis of Transanal Irrigation for Managing Neurogenic Bowel Dysfunction in Japan"],"prefix":"10.36469","volume":"6","author":[{"given":"Atsushi","family":"Sengoku","sequence":"first","affiliation":[{"name":"Hyogo Rehabilitation Center Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Noto","sequence":"additional","affiliation":[{"name":"Niigata University of Health and Welfare, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Nomi","sequence":"additional","affiliation":[{"name":"Hyogo Rehabilitation Center Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Emmanuel","sequence":"additional","affiliation":[{"name":"University College London Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsunori","family":"Murata","sequence":"additional","affiliation":[{"name":"CRECON Medical Assessment Inc., Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Mimura","sequence":"additional","affiliation":[{"name":"Center for Functional Bowel and Anorectal Disorders, Sashiogi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22273","published-online":{"date-parts":[[2018,2,12]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Harari D, Sarkarati M, Gurwitz JH, McGlinchey-Berroth G, Minaker KL. Constipation-related symptoms and bowel program concerning individuals with spinal cord injury. Spinal Cord. 1997;35(6):394-401.","DOI":"10.1038\/sj.sc.3100417"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Arwad RA. Neurogenic bowel dysfunction in patients with spinal cord injury, myelomeningocele, multiple sclerosis and Parkinson\u2019s disease. World J Gastroenterol. 2011;17(46):5035-5048.","DOI":"10.3748\/wjg.v17.i46.5035"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Roach MJ, Frost FS, Creasey G. Social and personal consequences of acquired bowel dysfunction for persons with spinal cord injury. J Spinal Cord Med. 2000;23(4):263-269.","DOI":"10.1080\/10790268.2000.11753535"},{"key":"ref3","unstructured":"Naicker AS, Roohi SA, Naicker MS, Zaleha O. Bowel dysfunction in spinal cord injury. Med J Malaysia. 2008;63(2):104-108."},{"key":"ref4","unstructured":"Sonnenberg A, Tsou VT, M\u00fcller AD. The \u201cinstitutional colon\u201d: a frequent colonic dysmotility in psychiatric and neurologic disease. Am J Gastroenterol. 1994;89(1):62-66."},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Preziosi G, Emmanuel A. Neurogenic bowel dysfunction: pathophysiology, clinical manifestations and treatment. Expert Rev Gastroenterol Hepatol. 2009;3(4):417-423.","DOI":"10.1586\/egh.09.31"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Coggrave M, Norton C, Wilson-Barnett J. Management of neurogenic bowel dysfunction in the community after spinal cord injury: a postal survey in the United Kingdom. Spinal Cord. 2009;47(4):323-330.","DOI":"10.1038\/sc.2008.137"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Krogh K, Nielsen J, Djurhuus JC, et al. Colorectal function in patients with spinal cord lesions. Dis Colon Rectum. 1997;40(10):1233-1239.","DOI":"10.1007\/bf02055170"},{"key":"ref8","unstructured":"Nomi M, Sengoku A. Evaluation of bowel dysfunction for patients with spinal cord injury using radio plaque markers and questionnaire (2nd report). JJASCoL. 2013;26(1):64-65."},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Krogh K, Christensen P, Laurberg S. Colorectal symptoms in patients with neurological diseases. Acta Neurol Scand. 2001;103(6):335-343.","DOI":"10.1034\/j.1600-0404.2001.103006335.x"},{"key":"ref10","unstructured":"Coggrave M, Ash D, Adcock C. Guidelines for management of neurogenic bowel dysfunction in individuals with central neurological conditions. Multidisciplinary Association of Spinal Cord Injured Professionals. 2012."},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Coggrave M, Norton C, Cody JD. Management of faecal incontinence and constipation in adults with central neurological diseases. Cochrane Database Syst Rev. January 2014. doi:10.1002\/14651858.cd002115.pub5","DOI":"10.1002\/14651858.cd002115.pub3"},{"key":"ref12","unstructured":"Drake MJ, Apostolidis A, Emmanuel A, et al. Neurologic Urinary and Fecal Incontinence. Paris: 5th International Consultation on Incontinence; 2013:827-954."},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Emmanuel AV, Krogh K, Bazzocchi G, et al. Consensus review of best practice of transanal irrigation in adults. Spinal Cord. 2013;51:732-738.","DOI":"10.1038\/sc.2013.86"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Emmanuel A. Review of the efficacy and safety of transanal irrigation for neurogenic bowel dysfunction. Spinal Cord. 2010;48(9):664-673.","DOI":"10.1038\/sc.2010.5"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Christensen P, Bazzocchi G, Coggrave M, et al. A randomized, controlled trial of TAI versus conservative bowel management in spinal cord-injured patients. Gastroenterology. 2006;131(3):738-747.","DOI":"10.1053\/j.gastro.2006.06.004"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Emmanuel A, Kumar G, Christensen P, et al. Long-term cost-effectiveness of transanal irrigation in patients with neurogenic bowel dysfunction. Cominelli F, ed. PLoS ONE. 2016;11(8):e0159394. doi:10.1371\/journal.pone.0159394","DOI":"10.1371\/journal.pone.0159394"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Christensen P, Andreasen J, Ehlers L. Cost-effectiveness of transanal irrigation versus conservative bowel management for spinal cord injury patients. Spinal Cord. 2009;47(2):138-143.","DOI":"10.1038\/sc.2008.98"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Del Popolo G, Mosiello G, Pilati C, et al. Treatment of neurogenic bowel dysfunction using transanal irrigation: a multicenter Italian study. Spinal Cord. 2008;46(7):517-522.","DOI":"10.1038\/sj.sc.3102167"},{"key":"ref19","unstructured":"Katoh S, Sengoku A, Nomi M, Noto S. A web based survey on neurogenic bowel dysfunction in Japan. JJASCoL. 2017;30(1):44-48."},{"key":"ref20","unstructured":"Analysis guideline for cost-effectiveness evaluation in Central Social Insurance Medical Council. http:\/\/www.mhlw.go.jp\/file\/05-Shingikai-12404000-Hokenkyoku-Iryouka\/0000104722.pdf. Accessed April 2017."},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Krogh K, Christensen P, Sabroe S, Laurberg S. Neurologic bowel dysfunction score. Spinal Cord. 2006;44:625-631.","DOI":"10.1038\/sj.sc.3101887"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Rivero-Arias O, Ouellet M, Gray A. Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome. Med Decis Making. 2010;30(3):341-354.","DOI":"10.1177\/0272989x09349961"},{"key":"ref23","unstructured":"National Institute for Health and Care Excellence (NICE). Guide to the methods of technology appraisal 2013. In: Process and Methods Guides No. 9. London; 2013."},{"key":"ref24","unstructured":"Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ. 1992;146:473-481."},{"key":"ref25","unstructured":"WHO. Cost-effectiveness thresholds. http:\/\/www.who.int\/choice\/costs\/CER_levels\/en\/."},{"key":"ref26","unstructured":"Cabinet office. National Economic Account Report. http:\/\/www.esri.cao.go.jp\/jp\/sna\/data\/data_list\/kakuhou\/files\/h26\/sankou\/pdf\/point20151225.pdf. Accessed April 2017."},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Ohkusa Y, Sugawara T. Research for willingness to pay for one QALY gain. Journal of Health and Society. 2006;16(2):157-165.","DOI":"10.4091\/iken.16.157"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Shiroiwa T, Fukuda T, Ikeda S, Takura T, Moriwaki K. Development of an official guideline for the economic evaluation of drugs\/medical devices in Japan. Value Health. 2017;20(3):372-378.","DOI":"10.1016\/j.jval.2016.08.726"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Shiroiwa T, Sung YK, Fukuda T, et al. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ. 2010;19:422-437.","DOI":"10.1002\/hec.1481"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Christensen P, Bazzocchi G, Coggrave M, et al. Outcome of transanal irrigation for bowel dysfunction in patients with spinal cord injury. J Spinal Cord Med. 2008;31(5):560-567.","DOI":"10.1080\/10790268.2008.11754571"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Watt M, Mealing S, Eaton J, et al. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart. 2012;98(5):370-376.","DOI":"10.1136\/heartjnl-2011-300444"}],"container-title":["Journal of Health Economics and Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/pmid\/32685570\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T14:40:27Z","timestamp":1748875227000},"score":1,"resource":{"primary":{"URL":"http:\/\/jheor.org\/article\/9781-cost-effectiveness-analysis-of-transanal-irrigation-for-managing-neurogenic-bowel-dysfunction-in-japan"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,12]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,29]]},"published-print":{"date-parts":[[2018,1,29]]}},"URL":"https:\/\/doi.org\/10.36469\/9781","archive":["Portico","Portico","Portico"],"relation":{},"ISSN":["2327-2236"],"issn-type":[{"value":"2327-2236","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,12]]},"article-number":"9781"}}